PAVmed
PAVM
9 hedge funds and large institutions have $1.69M invested in PAVmed in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0.01% more ownership
Funds ownership: 0.01% → 0.02% (+0.01%)
9% less capital invested
Capital invested by funds: $1.86M → $1.69M (-$174K)
18% less funds holding
Funds holding: 11 → 9 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$666K |
| 2 |
LCS
Levin Capital Strategies
New York
|
+$200K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$45.9K |
| 4 |
Jane Street
New York
|
+$23.8K |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
+$1.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$43K |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
-$16K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$11.6K |
| 4 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
-$1.22K |
| 5 |
BlackRock
New York
|
-$1K |
PAVM Hedge Fund Activity: Q2 2018 in Review
9 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2018, worth a combined $1.69M — down 9.3% from $1.86M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PAVM and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Sabby Management, adding an estimated $666K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $43K sold.
- 9 institutional investors held PAVmed (PAVM) as of Q2 2018, down from 11 in Q1 2018.
- Funds reported $1.69M of PAVmed stock for Q2 2018, down 9.3% quarter-over-quarter.
- 1 fund opened new PAVmed positions in Q2 2018 and 3 closed out, a net change of -2 holders.
- The largest PAVmed buyer in Q2 2018 was Sabby Management, an estimated $666K added.
- The largest PAVmed seller in Q2 2018 was Susquehanna International Group, an estimated $43K sold.
Based on aggregated 13F filings for Q2 2018.